All stock lists
Collegium Pharmaceutical, Inc (COLL)
NASDAQ: COLL · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
$25.43+$0.11 (+0.43%)
Insider Score
––Not scored
COLL Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
COLL Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $216.34 M | $199.88 M | $193.52 M | $205.45 M | $209.36 M |
| Revenue Growth (YoY) | 3.33 % | — | — | — | — |
| Cost of Revenue | $90.92 M | $89.59 M | $76.27 M | $77.07 M | $80.19 M |
| Gross Profit | $125.42 M | $110.29 M | $117.25 M | $128.38 M | $129.17 M |
| SG&A Expense | $99.59 M | $106.59 M | $86.35 M | $67.64 M | $67.10 M |
| R&D Expense | — | — | — | — | — |
| Operating Expenses | $99.59 M | $106.59 M | $86.35 M | $67.64 M | $67.10 M |
| Operating Income | $25.83 M | $3.70 M | $30.90 M | $60.74 M | $62.07 M |
| Pretax Income | $7.91 M | -$13.53 M | $18.74 M | $29.04 M | $43.44 M |
| Tax Provision | -$13.85 M | $1.52 M | $4.24 M | $12.07 M | $11.93 M |
| Net Income | $21.76 M | -$15.05 M | $14.50 M | $16.96 M | $31.51 M |
| EPS (Basic) | $0.69 | -$0.46 | $0.45 | $0.54 | $1.00 |
| EPS (Diluted) | $0.60 | -$0.46 | $0.40 | $0.46 | $0.84 |
| Shares Outstanding | 31.73 M | 32.46 M | 32.09 M | 31.65 M | 31.57 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
